FORM 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 30, 2012

 

 

BioMed Realty Trust, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland   1-32261   20-1142292

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File No.)

 

(I.R.S. Employer

Identification No.)

17190 Bernardo Center Drive

San Diego, California 92128

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (858) 485-9840

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 30, 2012, BioMed Realty Trust, Inc. (the “Company”) held its Annual Meeting of Stockholders, at which the stockholders voted on proposals as follows:

Proposal 1: Election of seven directors to serve until the 2013 Annual Meeting of Stockholders and until their successors are duly elected and qualify.

 

     Votes For      Votes For /
Votes Cast*
    Votes
Withheld
     Broker
Non-Votes
 

Alan D. Gold

     139,371,318         98.9     1,578,170         3,159,234   

Barbara R. Cambon

     140,511,211         99.7     438,277         3,159,234   

Edward A. Dennis, Ph.D.

     140,506,038         99.7     443,450         3,159,234   

Richard I. Gilchrist

     140,504,561         99.7     444,927         3,159,234   

Gary A. Kreitzer

     140,499,703         99.7     449,785         3,159,234   

Theodore D. Roth

     140,506,560         99.7     442,928         3,159,234   

M. Faye Wilson

     140,510,212         99.7     439,276         3,159,234   

 

* Represents the number voting “for” as a percentage of the total number of shares represented and voting at the meeting with respect to Proposal 1.

Proposal 2: Ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2012.

 

Votes For

   Votes Against    Abstentions    Broker Non-Votes
143,321,101    768,251    19,370    N/A

The number voting “for” constituted approximately 99.5% of the total number of shares represented and voting at the meeting with respect to Proposal 2.

Proposal 3: Resolution to approve, on an advisory basis, the compensation of the Company’s named executive officers.

 

Votes For

   Votes Against    Abstentions    Broker Non-Votes
137,905,493    2,985,477    58,518    3,159,234

The number voting “for” constituted approximately 97.8% of the total number of shares represented and voting at the meeting with respect to Proposal 3.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 1, 2012     BIOMED REALTY TRUST, INC.
    By:   /s/ Greg N. Lubushkin
    Name:   Greg N. Lubushkin
    Title:   Chief Financial Officer